1. Zhang W, Luo Y, Li J, Lin L, Ma Y, Hu C, et al. Wide dissemination of multidrug-resistant
Shigella isolates in China. J Antimicrob Chemother. 2011; 66:2527–2535. PMID:
21859815.
2. Christopher PR, David KV, John SM, Sankarapandian V. Antibiotic therapy for
Shigella dysentery. Cochrane Database Syst Rev. 2010; CD006784. PMID:
20687081.
3. Livermore DM, Mushtaq S, Nguyen T, Warner M. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae. Int J Antimicrob Agents. 2011; 37:405–409. PMID:
21276715.
Article
4. Bhattacharya D, Purushottaman SA, Bhattacharjee H, Thamizhmani R, Sudharama SD, Manimunda SP, et al. Rapid emergence of third-generation cephalosporin resistance in
Shigella sp. isolated in Andaman and Nicobar Islands, India. Microb Drug Resist. 2011; 17:329–332. PMID:
21352076.
5. Nguyen NT, Ha V, Tran NV, Stabler R, Pham DT, Le TM, et al. The sudden dominance of
blaCTX-M harbouring plasmids in
Shigella spp. Circulating in Southern Vietnam. PLoS Negl Trop Dis. 2010; 4:e702. PMID:
20544028.
6. Cheung TK, Chu YW, Tsang GK, Ngan JY, Hui IS, Kam KM. Emergence of CTX-M-type β-lactam resistance in
Shigella spp. in Hong Kong. Int J Antimicrob Agents. 2005; 25:350–352. PMID:
15784319.
7. Andres P, Petroni A, Faccone D, Pasterán F, Melano R, Rapoport M, et al. Extended-spectrum β-lactamases in
Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int J Antimicrob Agents. 2005; 25:501–507. PMID:
15878653.
8. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect. 2008; 14:33–41. PMID:
18154526.
Article
9. Hong SJ, Lee CH, Wang JH, Song W, Jung SH. Clinical characteristics of extended-spectrum β-lactamase producing
Shigella sonnei infection outbreaked in Chungju Area. Korean J Lab Med. 2006; 26:168–173. PMID:
18156720.
10. Kim S, Kim J, Kang Y, Park Y, Lee B. Occurrence of extended-spectrum β-lactamases in members of the genus
Shigella in the Republic of Korea. J Clin Microbiol. 2004; 42:5264–5269. PMID:
15528724.
11. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of
Shigella sonnei,
Escherichia coli, and
Klebsiella pneumoniae in Korea. J Clin Microbiol. 2001; 39:3747–3749. PMID:
11574608.
12. Lee SG, Jeong SH, Lee H, Kim CK, Lee Y, Koh E, et al. Spread of CTX-M-type extended-spectrum β-lactamases among bloodstream isolates of
Escherichia coli and
Klebsiella pneumoniae from a Korean hospital. Diagn Microbiol Infect Dis. 2009; 63:76–80. PMID:
19073302.
13. Park Y, Kang HK, Bae IK, Kim J, Kim JS, Uh Y, et al. Prevalence of the extended-spectrum β-lactamase and
qnr genes in clinical isolates of
Escherichia coli. Korean J Lab Med. 2009; 29:218–223. PMID:
19571619.
15. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-β-lactamase gene,
blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in
Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53:5046–5054. PMID:
19770275.
16. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005; 63:219–228. PMID:
15935499.
Article
17. Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010; 54:969–976. PMID:
19995920.
Article
18. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis. 2007; 58:349–355. PMID:
17449211.
Article
19. Li J, Ma Y, Hu C, Jin S, Zhang Q, Ding H, et al. Dissemination of cefotaxime-M-producing
Escherichia coli isolates in poultry farms, but not swine farms, in China. Foodborne Pathog Dis. 2010; 7:1387–1392. PMID:
20583961.
20. Sun Y, Zeng Z, Chen S, Ma J, He L, Liu Y, et al. High prevalence of
blaCTX-M extended-spectrum β-lactamase genes in
Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect. 2010; 16:1475–1481. PMID:
21681998.
21. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, et al. Prevalence and characterisation of CTX-M β-lactamases amongst
Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents. 2012; 39:305–310. PMID:
22325120.
22. Sjölund-Karlsson M, Howie R, Krueger A, Rickert R, Pecic G, Lupoli K, et al. CTX-M-producing non-Typhi
Salmonella spp. isolated from humans, United States. Emerg Infect Dis. 2011; 17:97–99. PMID:
21192864.
23. Tamang MD, Nam HM, Jang GC, Kim SR, Chae MH, Jung SC, et al. Molecular characterization of extended-spectrum β-lactamase and plasmid mediated AmpC β-lactamase-producing
Escherichia coli isolated from stray dogs from Korea. Antimicrob Agents Chemother. 2012; 56:2705–2712. PMID:
22354297.
24. Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother. 2002; 50:1031–1034. PMID:
12461028.
25. Yu F, Chen Q, Yu X, Li Q, Ding B, Yang L, et al. High prevalence of extended-spectrum β-lactamases among
Salmonella enterica Typhimurium isolates from pediatric patients with diarrhea in China. PLoS One. 2011; 6:e16801. PMID:
21390297.
26. Song W, Lee H, Lee K, Jeong SH, Bae IK, Kim JS, et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of
Escherichia coli from Korea. J Med Microbiol. 2009; 58:261–266. PMID:
19141747.
27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-second Informational supplement, M100-S22. 2012. Wayne, PA: Clinical and Laboratory Standards Institute.
28. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various
blaCTX-M genes. J Antimicrob Chemother. 2006; 57:14–23. PMID:
16291869.
29. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with
Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010; 54:3564–3568. PMID:
20547788.
30. Tham J, Walder M, Melander E, Odenholt I. Duration of colonization with extended-spectrum β-lactamase-producing
Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis. 2012; 44:573–577. PMID:
22292796.